tm
Seeing Is Believing
tm
Seeing Is Believing
LABP is currently covered by 1 analysts with an average price target of $38.75. This is a potential upside of $15.82 (68.99%) from yesterday's end of day stock price of $22.93.
Landos Biopharma's activity chart (see below) currently has 7 price targets and 11 ratings on display. The stock rating distribution of LABP is 100% SELL.
Analysts average stock forecasts to be materialized ratio is 38.89% with an average time for these price targets to be met of 154.5 days.
Highest price target for LABP is $4, Lowest price target is $4, average price target is $38.75.
Most recent stock forecast was given by CHRIS HOWERTON from JEFFERIES on 06-Jan-2023. First documented stock forecast 01-Mar-2021.
Currently out of the existing stock ratings of LABP, 1 are a SELL (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$14
1 years 10 months 17 days ago
(06-Jan-2023)
1/2 (50%)
$2 (16.67%)
713
Hold
$3
2 years 12 days ago
(11-Nov-2022)
1/3 (33.33%)
$-7.6 (-71.70%)
87
Buy
2 years 3 months 11 days ago
(12-Aug-2022)
0/1 (0%)
$167.4 (102.95%)
Hold
$15
$8.43 (128.31%)
$170
2 years 10 months 20 days ago
(03-Jan-2022)
1/2 (50%)
$-37.2 (-71.26%)
64
Buy
$45
$41.62 (1231.36%)
$45
3 years 5 days ago
(18-Nov-2021)
2/2 (100%)
$-53.8 (-54.45%)
63
What is LABP (Landos Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on LABP (Landos Biopharma) with a proven track record?
Which analyst has the current lower performing score on LABP (Landos Biopharma) with a proven track record?
Which analyst has the most public recommendations on LABP (Landos Biopharma)?
Which analyst is the currently most bullish on LABP (Landos Biopharma)?
Which analyst is the currently most reserved on LABP (Landos Biopharma)?
